Trial intelligence / Profile preview

Wound Infiltration With Bupivacaine for Laparoscopic Appendectomy

NCT03481517Phase 4Completed

Sponsor
National Taiwan University Hospital
Start
Apr 2018
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in appendicitis, sponsored by National Taiwan University Hospital. Started Apr 2018; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

appendicitis

Beyond the preview

Go deeper on NCT03481517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03481517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call